NCT04617236 (CLS) is a NA clinical trial of Cultivando La Salud in Breast Cancer, sponsored by University of Puerto Rico.

Who is sponsoring NCT04617236?

NCT04617236 is sponsored by University of Puerto Rico.

What drugs are being tested in NCT04617236?

Interventions in NCT04617236: Cultivando La Salud.

What condition does NCT04617236 study?

NCT04617236 studies Breast Cancer, Cervical Cancer.

Is NCT04617236 still recruiting?

NCT04617236 is currently completed. Last updated 5 November 2020.

Last reviewed 2020-11-05 · How we verify

NCT04617236: CLS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cultivando la Salud: A Breast and Cervical Cancer Screening Promotion Program for Low-Income Puerto Rican Women

Completed NA Last updated 5 November 2020

What this trial tests

NA trial testing Cultivando La Salud in Breast Cancer in 444 participants. Completed in 2 July 2020.

Timeline

15 May 2012

Primary endpoint
20 September 2013

2 July 2020

Quick facts

Lead sponsor	University of Puerto Rico
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	single
Primary purpose	screening
Enrollment	444
Start date	15 May 2012
Primary completion	20 September 2013
Estimated completion	2 July 2020
Sites	1 location across Puerto Rico

Drugs / interventions tested

Cultivando La Salud

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Cervical Cancer — all drugs for Cervical Cancer →

Sponsor

University of Puerto Rico

Who can join

21 and older, female only, with Breast Cancer or Cervical Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goal of this education program is to increase breast and cervical cancer screening in low-income women in Puerto Rico through implementation of an evidence-based educational program that addresses both health professionals (promotoras or community health workers) and public audiences of low-income women living in Canóvanas, Puerto Rico who have either never been screened for breast and/or cervical cancer, or are under-screened according recommended guidelines. To evaluate promotoras' delivery of the CLS screening education program we used a randomized pre-post comparison group study design that will provide data to determine the effectiveness of the CLS intervention program compared with usual practice (no intervention).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other University of Puerto Rico trials

Trials by the same sponsor.

NCT06425510 — Using Technology to Improve Function for Older Latinos With Disabilities in Underserved Areas · NA · not yet recruiting
NCT07369102 — Esketamine With or Without Integration Therapy for Treatment-Resistant Depression · Phase 4 · recruiting
NCT07039266 — Food Allergy Registry and Awareness Campaign in Puerto Rico · not yet recruiting
NCT06917118 — Multimodal Pain Management After Wide Awake Local Anesthesia No Tourniquet Orthopedic Hand Surgery: A Randomized Control · NA · not yet recruiting
NCT05910749 — Substance Use Disorder, Brain and Behavioral Regulation · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04617236 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Puerto Rico
Last refreshed: 5 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04617236.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing